Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on DC STEM Digest.
Press releases published on May 29, 2025
NextCure and LigaChemBio to Present Trial in Progress Poster for LNCB74, a B7-H4 Targeted Antibody-Drug Conjugate, as Monotherapy in Participants with Advanced Solid Tumors at ASCO 2025
GlobeNewswire
·
May 29, 2025
LNCB74 is in a Phase 1, open-label, first-in-human study that will include dose escalation, safety, and biomarker backfills and randomized dose expansion/optimization The study is currently enrolling in dose escalation Poster to be presented June 2, 2025, …
Vaxart to Participate at the Jefferies Global Healthcare Conference on June 5, 2025
GlobeNewswire
·
May 29, 2025
SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today announced that members …
AGM Group Holdings Inc. Announces Effective Date of 50 for 1 Share Consolidation
GlobeNewswire
·
May 29, 2025
Beijing, May 29, 2025 (GLOBE NEWSWIRE) -- AGM Group Holdings Inc. (“AGM Holdings” or the “Company”) (NASDAQ: AGMH), an integrated technology company specializing in the assembling and sales of high-performance hardware and computing equipment, today …
Amneal to Participate at Upcoming Investor Conferences in June
GlobeNewswire
·
May 29, 2025
BRIDGEWATER, N.J., May 29, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) will participate in two upcoming investor conferences: Jefferies Global Healthcare Conference on June 5, 2025, with company presentation at 9:20 AM ET, and …
Annexon Biosciences to Present at the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 29, 2025
BRISBANE, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory …
Zscaler Reports Third Quarter Fiscal 2025 Financial Results
GlobeNewswire
·
May 29, 2025
Third Quarter Highlights Revenue grows 23% year-over-year to $678.0 million Calculated billings grows 25% year-over-year to $784.5 million Deferred revenue grows 26% year-over-year to $1,985.0 million GAAP net loss of $4.1 million compared to GAAP net …
Terns Pharmaceuticals to Participate in Upcoming June Investor Conferences
GlobeNewswire
·
May 29, 2025
FOSTER CITY, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, …
Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences
GlobeNewswire
·
May 29, 2025
SAN FRANCISCO, May 29, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, today announced that management will …
Avadel Pharmaceuticals to Present New Data on LUMRYZ™ (sodium oxybate) For Extended-Release Oral Suspension at SLEEP 2025
GlobeNewswire
·
May 29, 2025
– 14 abstracts accepted, including four oral presentations – – Interim analysis of real-world REFRESH study demonstrated clinically significant efficacy and improvement of EDS for patients who switched from twice-nightly oxybate to once-at-bedtime LUMRYZ – …
Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences
GlobeNewswire
·
May 29, 2025
LONDON, May 29, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will present at the following investor conferences in June: Jefferies 2025 Global Healthcare Conference on Thursday, June 5 …
Gyre Therapeutics Announces Closing of its Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
GlobeNewswire
·
May 29, 2025
SAN DIEGO, May 29, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic disease, today …
Arcutis to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire
·
May 29, 2025
WESTLAKE VILLAGE, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis …
Mavenir kooperiert mit Three UK und Red Hat: 5G-Geschwindigkeit in Glasgow durch ersten Open-RAN-Kleinzellen-Rollout in Großbritannien verdoppelt
GlobeNewswire
·
May 29, 2025
Mavenir Open vRAN und O-RAN-konforme Small Cells sind entscheidend für den Erfolg der Einführung von Three UK im Stadtzentrum von Glasgow – sie verbessern die Netzabdeckung und Kapazität in einem stark frequentierten, dicht bebauten Stadtgebiet …
Colaboración de Mavenir con Three UK y Red Hat duplica las velocidades 5G en Glasgow en el primer lanzamiento de celdas pequeñas Open RAN en el Reino Unido
GlobeNewswire
·
May 29, 2025
Las celdas pequeñas Open vRAN y compatibles con O-RAN de Mavenir son fundamentales para el éxito del lanzamiento de Three UK en el centro de la ciudad de Glasgow, aumentando la cobertura y la capacidad en un entorno urbano denso y de alta demanda La prueba …
שיתוף פעולה של Mavenir עם Three UK ו-Red Hat מכפיל את מהירויות ה-5G בגלזגו בפריסת תאי Open RAN קטנים ראשונה בבריטניה
GlobeNewswire
·
May 29, 2025
לתאים הקטנים תואמי Open vRAN ו-O-RAN של Mavenir יש חלק מרכזי בהצלחת הפריסה של Three UK במרכז גלזגו - שמחזקת את הכיסוי והקיבולת בסביבה עירונית צפופה בה הביקוש גבוה ניסוי פורץ דרך מדגים את היתרון של פריסת תאי Open RAN קטנים לצד רשתות מאקרו קיימות כדי לפתור …
Mavenir, Three UK et Red Hat, une collaboration qui marque le premier déploiement de petites cellules Open RAN au Royaume-Uni et permet de doubler la vitesse de la 5G à Glasgow
GlobeNewswire
·
May 29, 2025
Les petites cellules Open vRAN (ou Réseau d’Accès Radio Ouvert virtualisé) de Mavenir sont conformes à la norme O-RAN. Elles sont au cœur du succès du déploiement de Three UK dans le centre-ville de Glasgow et améliorent la couverture et la capacité dans …
マベニア (Mavenir)、スリーUK (Three UK) およびレッドハット (Red Hat) と提携し、英国初のオープンRAN (Open RAN) スモールセル展開によりグラスゴーの5G通信速度を2倍に向上
GlobeNewswire
·
May 29, 2025
マベニアのオープンvRAN (Open vRAN) およびO-RAN準拠のスモールセルは、スリーUKによるグラスゴー市中心部における展開の成功で中心的役割を果たし、高需要・高密度の都市環境全体のカバレッジと容量を拡大 この画期的なトライアルは、ブラックスポットの問題を解決するために、既存のマクロネットワークと共にオープンRANスモールセルを展開することの利点を実証する スコットランド・グラスゴー発 , May 30, 2025 (GLOBE NEWSWIRE) -- …
Kolaborasi Mavenir dengan Three UK dan Red Hat Gandakan Kecepatan 5G Glasgow dalam Peluncuran Small Cells Open RAN Pertama di Inggris
GlobeNewswire
·
May 29, 2025
Small cells Mavenir Open vRAN dan berstandar O-RAN menjadi kunci keberhasilan peluncuran Three UK di Pusat Kota Glasgow, karena mampu meningkatkan cakupan dan kapasitas di lingkungan perkotaan padat dengan permintaan tinggi Uji coba penting ini menunjukkan …
Colaboração da Mavenir com Three UK e Red Hat Dobra a Velocidade 5G em Glasgow no Lançamento do UK-First Open RAN Small Cells Roll-Out
GlobeNewswire
·
May 29, 2025
Small cells compatíveis com Mavenir Open vRAN e O-RAN centrais para o sucesso da implantação no Glasgow City Centre do Three UK – aumentando a cobertura e a capacidade em um ambiente urbano denso e de alta demanda O teste decisivo demonstra o benefício da …
Mavenir จับมือกับ Three UK และ Red Hat เพื่อทวีความเร็ว 5G ในเมืองกลาสโกว์เป็นสองเท่าในการเปิดตัว Open RAN Small Cells…
GlobeNewswire
·
May 29, 2025
เซลล์ขนาดเล็กที่ทำงานร่วมกันได้กับ Open vRAN และ O-RAN ของ Mavenir ซึ่งถือเป็นศูนย์กลางแห่งความสำเร็จของการเปิดตัวศูนย์กลางเมืองกลาสโกว์ของ Three UK ช่วยเพิ่มความครอบคลุมและความจุในสภาพแวดล้อมเมืองที่มีความต้องการสูงและหนาแน่น …